HOME OUR COMPANIES OUR CULTURE PRODUCTS NEWS ROOM RESOURCES CAREERS Unconventional Thinking Our people aren’t afraid to challenge convention. This approach can lead to something new, something better. Learn More ABOUT OTSUKA At Otsuka, we dream and act like a big venture company. LATEST NEWS September 29, 2014 U.S. FDA Approves Dual-Chamber Syringe for Abilify Maintena® (aripiprazole) Extended-Release Injectable Suspension for the Treatment of Schizophrenia

HOME OUR COMPANIES OUR CULTURE PRODUCTS NEWS ROOM RESOURCES CAREERS OPDC Leadership Research & Development Compliance WELCOME TO OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION Established in 2007, Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) is a part of the Otsuka Group (Otsuka) responsible for the research and clinical development of healthcare products.

HOME OUR COMPANIES OUR CULTURE PRODUCTS NEWS ROOM RESOURCES CAREERS About Us U.S. News Releases Global News Releases News Archive OAPI Leadership OPDC Leadership MEDIA CONTACTS Media Contact/Public Relations (U.S.) Kevin Wiggins Corporate Communications Otsuka America Pharmaceutical, Inc. Princeton, NJ 08540 USA (609) 249-7292

HOME OUR COMPANIES OUR CULTURE PRODUCTS NEWS ROOM RESOURCES CAREERS Patient Assistance Sponsorships and Grants Returned Goods Policy for U.S. Authorized Distributor of Record AUTHORIZED DISTRIBUTOR OF RECORD AmerisourceBergen Corporation Wholesale/Distributor All OAPI Products Bellco Drug Corporation Wholesale/Distributor All OAPI Products